A股異動|物聯網概念股逆市走強2019年華為全聯接大會召開在即
格隆匯8月15日丨物聯網概念股逆市走強,其中美格智能(002881.SZ)漲停,思創醫惠(300078.SZ)漲逾6%。

2019年華為全聯接大會將於2019年9月18日-20日在上海世博展覽館舉行,大會將圍繞數字技術創新、數字智慧園區、雲+AI+5G+IoT、華為AI全棧能力等領域重點展開。
此前,華為在開發者大會上帶來了鴻蒙系統+智慧屏,以及其物聯網解決方案。機構認為,基於“鴻蒙系統+智慧屏”的整個物聯網的生態體系雛形已經初步構建完成,以這個框架雛形為基礎,未來更多的智能終端設備、應用場景或加速湧現,帶動半導體、元器件、大數據等相關產業發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.